Registered entities
Flex Pharma, Inc.
Reg. No. 1615219United States
Flex Pharma, Inc
Reg. No. 46-5087339United States
Innovation
10 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 233 times.
| Year | Filings |
|---|---|
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 2 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Investor mix
13 investors on record; lead investors include Longwood Fund, Bessemer Venture Partners, EcoR1, Lightstone Ventures; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 46% |
| Private equity | 1 | 8% |
| Angel & family office | 1 | 8% |
| Other / undisclosed | 5 | 38% |